{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:24:02Z","timestamp":1790717042299,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T00:00:00Z","timestamp":1672272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1A2B3008621"],"award-info":[{"award-number":["2017R1A2B3008621"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Regulatory T (Treg) cells maintain immune homeostasis by preventing abnormal or excessive immune responses. Histone deacetylase 6 (HDAC6) regulates expression of Foxp3, and thus, Treg cell differentiation; however, its role in Treg cell differentiation is unclear and somewhat controversial. Here, we investigated the role of HDAC6 in TGF-\u03b2-induced murine Treg cells. HDAC6 expression was higher in Treg cells than in other T helper cell subsets. Pharmacological inhibitors of HDAC6 selectively inhibited Treg cell differentiation and suppressive function. A specific HDAC6 inhibitor induced changes in global gene expression by Treg cells. Of these changes, genes related to cell division were prominently affected. In summary, HDAC6 plays an important role in TGF-\u03b2-induced murine Treg cell differentiation by regulating cell proliferation.<\/jats:p>","DOI":"10.1038\/s41598-022-27230-7","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T15:05:26Z","timestamp":1672326326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Histone deacetylase 6 plays an important role in TGF-\u03b2-induced murine Treg cell differentiation by regulating cell proliferation"],"prefix":"10.1038","volume":"12","author":[{"given":"Ji Hyeon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Woong","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gap Ryol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,29]]},"reference":[{"issue":"3","key":"27230_CR1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","volume":"155","author":"S Sakaguchi","year":"1995","unstructured":"Sakaguchi, S. et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155(3), 1151\u20131164 (1995).","journal-title":"J. Immunol."},{"issue":"5","key":"27230_CR2","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi, S. et al. Regulatory T cells and immune tolerance. Cell 133(5), 775\u2013787 (2008).","journal-title":"Cell"},{"issue":"1","key":"27230_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1600-065X.2011.01018.x","volume":"241","author":"AY Rudensky","year":"2011","unstructured":"Rudensky, A. Y. Regulatory T cells and Foxp3. Immunol. Rev. 241(1), 260\u2013268 (2011).","journal-title":"Immunol. Rev."},{"issue":"5","key":"27230_CR4","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.immuni.2009.05.002","volume":"30","author":"MAC de Lafaille","year":"2009","unstructured":"de Lafaille, M. A. C. & Lafaille, J. J. Natural and adaptive foxp3+ regulatory T cells: More of the same or a division of labor?. Immunity 30(5), 626\u2013635 (2009).","journal-title":"Immunity"},{"issue":"2","key":"27230_CR5","first-page":"116","volume":"6","author":"X Lin","year":"2013","unstructured":"Lin, X. et al. Advances in distinguishing natural from induced Foxp3+ regulatory T cells. Int. J. Clin. Exp. Pathol. 6(2), 116 (2013).","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"7","key":"27230_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DA Vignali","year":"2008","unstructured":"Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. Nat. Rev. Immunol. 8(7), 523\u2013532 (2008).","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"27230_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.molmed.2007.01.003","volume":"13","author":"M Miyara","year":"2007","unstructured":"Miyara, M. & Sakaguchi, S. Natural regulatory T cells: Mechanisms of suppression. Trends Mol. Med. 13(3), 108\u2013116 (2007).","journal-title":"Trends Mol. Med."},{"issue":"1","key":"27230_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","volume":"30","author":"SZ Josefowicz","year":"2012","unstructured":"Josefowicz, S. Z., Lu, L.-F. & Rudensky, A. Y. Regulatory T cells: Mechanisms of differentiation and function. Annu. Rev. Immunol. 30(1), 531\u2013564 (2012).","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"27230_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/cr.2016.151","volume":"27","author":"A Tanaka","year":"2017","unstructured":"Tanaka, A. & Sakaguchi, S. Regulatory T cells in cancer immunotherapy. Cell Res. 27(1), 109\u2013118 (2017).","journal-title":"Cell Res."},{"issue":"1","key":"27230_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","volume":"212","author":"S Sakaguchi","year":"2006","unstructured":"Sakaguchi, S. et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol. Rev. 212(1), 8\u201327 (2006).","journal-title":"Immunol. Rev."},{"issue":"9","key":"27230_CR11","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1172\/JCI200423395","volume":"114","author":"Z Feh\u00e9rvari","year":"2004","unstructured":"Feh\u00e9rvari, Z. & Sakaguchi, S. CD4+ Tregs and immune control. J. Clin. Investig. 114(9), 1209\u20131217 (2004).","journal-title":"J. Clin. Investig."},{"issue":"1","key":"27230_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/83784","volume":"27","author":"ME Brunkow","year":"2001","unstructured":"Brunkow, M. E. et al. Disruption of a new forkhead\/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27(1), 68\u201373 (2001).","journal-title":"Nat. Genet."},{"issue":"40","key":"27230_CR13","doi-asserted-by":"publisher","first-page":"37672","DOI":"10.1074\/jbc.M104521200","volume":"276","author":"LA Schubert","year":"2001","unstructured":"Schubert, L. A., Jeffery, E., Zhang, Y., Ramsdell, F. & Ziegler, S. F. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J. Biol. Chem. 276(40), 37672\u201337679 (2001).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"27230_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat. Immunol. 4(4), 330\u2013336 (2003).","journal-title":"Nat. Immunol."},{"issue":"5609","key":"27230_CR15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609), 1057\u20131061 (2003).","journal-title":"Science"},{"issue":"5","key":"27230_CR16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ni1455","volume":"8","author":"Y Zheng","year":"2007","unstructured":"Zheng, Y. & Rudensky, A. Y. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8(5), 457\u2013462 (2007).","journal-title":"Nat. Immunol."},{"issue":"1","key":"27230_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett, C. L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27(1), 20\u201321 (2001).","journal-title":"Nat. Genet."},{"issue":"12","key":"27230_CR18","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1172\/JCI11679","volume":"106","author":"TA Chatila","year":"2000","unstructured":"Chatila, T. A. et al. JM2, encoding a fork head\u2013related protein, is mutated in X-linked autoimmunity\u2013allergic disregulation syndrome. J. Clin. Investig. 106(12), R75\u2013R81 (2000).","journal-title":"J. Clin. Investig."},{"issue":"1","key":"27230_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/83707","volume":"27","author":"RS Wildin","year":"2001","unstructured":"Wildin, R. S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27(1), 18\u201320 (2001).","journal-title":"Nat. Genet."},{"issue":"1","key":"27230_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40246-015-0041-3","volume":"9","author":"M Trerotola","year":"2015","unstructured":"Trerotola, M. et al. Epigenetic inheritance and the missing heritability. Hum. Genomics 9(1), 17 (2015).","journal-title":"Hum. Genomics"},{"issue":"5","key":"27230_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrg2540","volume":"10","author":"H Cedar","year":"2009","unstructured":"Cedar, H. & Bergman, Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10(5), 295\u2013304 (2009).","journal-title":"Nat. Rev. Genet."},{"issue":"4","key":"27230_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0968-0004(97)01016-5","volume":"22","author":"PA Wade","year":"1997","unstructured":"Wade, P. A., Pruss, D. & Wolffe, A. P. Histone acetylation: Chromatin in action. Trends Biochem. Sci. 22(4), 128\u2013132 (1997).","journal-title":"Trends Biochem. Sci."},{"issue":"3","key":"27230_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0092-8674(00)80211-1","volume":"89","author":"MJ Pazin","year":"1997","unstructured":"Pazin, M. J. & Kadonaga, J. T. What\u2019s up and down with histone deacetylation and transcription?. Cell 89(3), 325\u2013328 (1997).","journal-title":"Cell"},{"issue":"5","key":"27230_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1101\/gad.12.5.599","volume":"12","author":"K Struhl","year":"1998","unstructured":"Struhl, K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12(5), 599\u2013606 (1998).","journal-title":"Genes Dev."},{"issue":"3","key":"27230_CR25","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"AJD Ruijter","year":"2003","unstructured":"Ruijter, A. J. D. et al. Histone deacetylases (HDACs): Characterization of the classical HDAC family. Biochem. J. 370(3), 737\u2013749 (2003).","journal-title":"Biochem. J."},{"issue":"4","key":"27230_CR26","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto, E. & Yoshida, M. Erasers of histone acetylation: The histone deacetylase enzymes. Cold Spring Harb. Perspect. Biol. 6(4), a018713 (2014).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"10","key":"27230_CR27","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","volume":"5","author":"M Dokmanovic","year":"2007","unstructured":"Dokmanovic, M., Clarke, C. & Marks, P. A. Histone deacetylase inhibitors: Overview and perspectives. Mol. Cancer Res. 5(10), 981\u2013989 (2007).","journal-title":"Mol. Cancer Res."},{"issue":"6887","key":"27230_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/417455a","volume":"417","author":"C Hubbert","year":"2002","unstructured":"Hubbert, C. et al. HDAC6 is a microtubule-associated deacetylase. Nature 417(6887), 455\u2013458 (2002).","journal-title":"Nature"},{"key":"27230_CR29","doi-asserted-by":"crossref","unstructured":"Kaur, S., P. Rajoria, and M. Chopra, HDAC6: A unique HDAC family member as a cancer target. Cell Oncol (Dordr), 2022.","DOI":"10.1007\/s13402-022-00704-6"},{"issue":"3","key":"27230_CR30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","volume":"38","author":"N Ohkura","year":"2013","unstructured":"Ohkura, N., Kitagawa, Y. & Sakaguchi, S. Development and maintenance of regulatory T cells. Immunity 38(3), 414\u2013423 (2013).","journal-title":"Immunity"},{"issue":"10","key":"27230_CR31","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1128\/MCB.05155-11","volume":"31","author":"EF de Zoeten","year":"2011","unstructured":"de Zoeten, E. F. et al. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3+ T-regulatory cells. Mol. Cell. Biol. 31(10), 2066\u20132078 (2011).","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"27230_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/1759-7714.12974","volume":"10","author":"J Ran","year":"2019","unstructured":"Ran, J. & Zhou, J. Targeted inhibition of histone deacetylase 6 in inflammatory diseases. Thorac. Cancer 10(3), 405\u2013412 (2019).","journal-title":"Thorac. Cancer"},{"issue":"8","key":"27230_CR33","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/2159-8290.CD-16-1020","volume":"7","author":"DO Adeegbe","year":"2017","unstructured":"Adeegbe, D. O. et al. Synergistic immunostimulatory effects and therapeutic benefit of combined histone deacetylase and bromodomain inhibition in non-small cell lung cancer HDAC and BRD inhibition as immunotherapeutics in NSCLC. Cancer Discov. 7(8), 852\u2013867 (2017).","journal-title":"Cancer Discov."},{"issue":"9","key":"27230_CR34","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1038\/s41375-018-0062-8","volume":"32","author":"J Bae","year":"2018","unstructured":"Bae, J. et al. Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors. Leukemia 32(9), 1932\u20131947 (2018).","journal-title":"Leukemia"},{"issue":"1","key":"27230_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40425-019-0517-0","volume":"7","author":"AS Laino","year":"2019","unstructured":"Laino, A. S. et al. HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics. J. Immunother. Cancer 7(1), 1\u201316 (2019).","journal-title":"J. Immunother. Cancer"},{"issue":"31","key":"27230_CR36","doi-asserted-by":"publisher","first-page":"10842","DOI":"10.1021\/ja102758v","volume":"132","author":"KV Butler","year":"2010","unstructured":"Butler, K. V. et al. Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A. J. Am. Chem. Soc. 132(31), 10842\u201310846 (2010).","journal-title":"J. Am. Chem. Soc."},{"key":"27230_CR37","doi-asserted-by":"publisher","first-page":"19626","DOI":"10.1038\/srep19626","volume":"6","author":"Z Wang","year":"2016","unstructured":"Wang, Z. et al. Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: Potential roles of \u03b1-tubulin acetylation and FGF-21 up-regulation. Sci. Rep. 6, 19626 (2016).","journal-title":"Sci. Rep."},{"issue":"10","key":"27230_CR38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0167-5699(00)01712-6","volume":"21","author":"J Rengarajan","year":"2000","unstructured":"Rengarajan, J., Szabo, S. J. & Glimcher, L. H. Transcriptional regulation of Th1\/Th2 polarization. Immunol. Today 21(10), 479\u2013483 (2000).","journal-title":"Immunol. Today"},{"issue":"4","key":"27230_CR39","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/ni0407-345","volume":"8","author":"E Bettelli","year":"2007","unstructured":"Bettelli, E., Oukka, M. & Kuchroo, V. K. TH-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8(4), 345\u2013350 (2007).","journal-title":"Nat. Immunol."},{"issue":"2","key":"27230_CR40","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/npp.2013.207","volume":"39","author":"J Jochems","year":"2014","unstructured":"Jochems, J. et al. Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability. Neuropsychopharmacology 39(2), 389\u2013400 (2014).","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"27230_CR41","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s13311-016-0501-z","volume":"14","author":"V Benoy","year":"2017","unstructured":"Benoy, V. et al. Development of improved HDAC6 inhibitors as pharmacological therapy for axonal Charcot\u2013Marie\u2013Tooth disease. Neurotherapeutics 14(2), 417\u2013428 (2017).","journal-title":"Neurotherapeutics"},{"issue":"39","key":"27230_CR42","doi-asserted-by":"publisher","first-page":"15704","DOI":"10.1073\/pnas.1313893110","volume":"110","author":"J-H Lee","year":"2013","unstructured":"Lee, J.-H. et al. Development of a histone deacetylase 6 inhibitor and its biological effects. Proc. Natl. Acad. Sci. 110(39), 15704\u201315709 (2013).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"22","key":"27230_CR43","doi-asserted-by":"publisher","first-page":"9891","DOI":"10.1021\/jm301098e","volume":"55","author":"JA Bergman","year":"2012","unstructured":"Bergman, J. A. et al. Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth. J. Med. Chem. 55(22), 9891\u20139899 (2012).","journal-title":"J. Med. Chem."},{"issue":"28","key":"27230_CR44","doi-asserted-by":"publisher","first-page":"17174","DOI":"10.1016\/S0021-9258(17)44885-X","volume":"265","author":"M Yoshida","year":"1990","unstructured":"Yoshida, M. et al. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265(28), 17174\u201317179 (1990).","journal-title":"J. Biol. Chem."},{"issue":"10","key":"27230_CR45","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1084\/jem.20082771","volume":"206","author":"L Klotz","year":"2009","unstructured":"Klotz, L. et al. The nuclear receptor PPAR\u03b3 selectively inhibits Th17 differentiation in a T cell\u2013intrinsic fashion and suppresses CNS autoimmunity. J. Exp. Med. 206(10), 2079\u20132089 (2009).","journal-title":"J. Exp. Med."},{"issue":"7404","key":"27230_CR46","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature11132","volume":"486","author":"D Cipolletta","year":"2012","unstructured":"Cipolletta, D. et al. PPAR-\u03b3 is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486(7404), 549\u2013553 (2012).","journal-title":"Nature"},{"issue":"12","key":"27230_CR47","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","volume":"41","author":"Y He","year":"2016","unstructured":"He, Y., Hara, H. & N\u00fa\u00f1ez, G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem. Sci. 41(12), 1012\u20131021 (2016).","journal-title":"Trends Biochem. Sci."},{"issue":"47","key":"27230_CR48","doi-asserted-by":"publisher","first-page":"17951","DOI":"10.1074\/jbc.RA119.010545","volume":"294","author":"S-H Park","year":"2019","unstructured":"Park, S.-H. et al. NLRP3 negatively regulates Treg differentiation through Kpna2-mediated nuclear translocation. J. Biol. Chem. 294(47), 17951\u201317961 (2019).","journal-title":"J. Biol. Chem."},{"issue":"5","key":"27230_CR49","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","volume":"138","author":"Z Wang","year":"2009","unstructured":"Wang, Z. et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 138(5), 1019\u20131031 (2009).","journal-title":"Cell"},{"issue":"1","key":"27230_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1600-065X.2010.00923.x","volume":"236","author":"LM Francisco","year":"2010","unstructured":"Francisco, L. M., Sage, P. T. & Sharpe, A. H. The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236(1), 219\u2013242 (2010).","journal-title":"Immunol. Rev."},{"issue":"7130","key":"27230_CR51","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nature05563","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng, Y. et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445(7130), 936\u2013940 (2007).","journal-title":"Nature"},{"issue":"11","key":"27230_CR52","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1101\/gad.1791009","volume":"23","author":"L-F Lu","year":"2009","unstructured":"Lu, L.-F. & Rudensky, A. Molecular orchestration of differentiation and function of regulatory T cells. Genes Dev. 23(11), 1270\u20131282 (2009).","journal-title":"Genes Dev."},{"issue":"2","key":"27230_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1011","volume":"7","author":"T Sadlon","year":"2018","unstructured":"Sadlon, T. et al. Unravelling the molecular basis for regulatory T-cell plasticity and loss of function in disease. Clin. Transl. Immunol. 7(2), e1011 (2018).","journal-title":"Clin. Transl. Immunol."},{"issue":"4","key":"27230_CR54","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.7150\/thno.17615","volume":"7","author":"B Yan","year":"2017","unstructured":"Yan, B. et al. HDAC6 regulates IL-17 expression in T lymphocytes: implications for HDAC6-targeted therapies. Theranostics 7(4), 1002 (2017).","journal-title":"Theranostics"},{"issue":"5","key":"27230_CR55","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.4049\/jimmunol.176.5.2808","volume":"176","author":"G Raimondi","year":"2006","unstructured":"Raimondi, G. et al. Regulated compartmentalization of programmed cell death-1 discriminates CD4+ CD25+ resting regulatory T cells from activated T cells. J. Immunol. 176(5), 2808\u20132816 (2006).","journal-title":"J. Immunol."},{"issue":"37","key":"27230_CR56","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","volume":"26","author":"W Xu","year":"2007","unstructured":"Xu, W., Parmigiani, R. & Marks, P. Histone deacetylase inhibitors: Molecular mechanisms of action. Oncogene 26(37), 5541\u20135552 (2007).","journal-title":"Oncogene"},{"key":"27230_CR57","doi-asserted-by":"crossref","unstructured":"Aldana-Masangkay, G.I. and K.M. Sakamoto, The role of HDAC6 in cancer. Journal of Biomedicine and Biotechnology, 2010. 2011.","DOI":"10.1155\/2011\/875824"},{"key":"27230_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105274","volume":"163","author":"S Pulya","year":"2021","unstructured":"Pulya, S. et al. HDAC6 as privileged target in drug discovery: A perspective. Pharmacol. Res. 163, 105274 (2021).","journal-title":"Pharmacol. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27230-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27230-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27230-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,19]],"date-time":"2023-03-19T11:34:22Z","timestamp":1679225662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-27230-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,29]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["27230"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-27230-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,29]]},"assertion":[{"value":"1 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22550"}}